Coral Jimenez Rovira
Endocrinology, Diabetes & Metabolism · Vega Baja, PRNPI 1326665746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 8.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,149 and has fallen 54.6% since, to $975 in 2025. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in PR, where the typical reported total is $4,706.
Across 185 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$370
- Dexcom, Inc.$309
- Xeris Pharmaceuticals, Inc.$305
- Lilly USA, LLC$289
- Kyowa Kirin, Inc.$258
- Corcept Therapeutics$257
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,283100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 9 | $370 |
| Dexcom, Inc. | 11 | $309 |
| Xeris Pharmaceuticals, Inc. | 15 | $305 |
| Lilly USA, LLC | 16 | $289 |
| Kyowa Kirin, Inc. | 8 | $258 |
| Corcept Therapeutics | 13 | $257 |
| Novo Nordisk | 10 | $252 |
| Amgen | 9 | $239 |
| Insulet Corporation | 17 | $235 |
| Bayer | 11 | $208 |
| Boehringer Ingelheim | 10 | $207 |
| Tandem Diabetes Care, Inc. | 5 | $187 |
| AbbVie | 4 | $174 |
| Recordati_rare_diseases_inc. | 7 | $140 |
| Novartis | 7 | $126 |
| Boston Scientific | 1 | $118 |
| Eli Lilly Export S.A. Puerto Rico Branch | 4 | $80 |
| Mannkind Corporation | 5 | $79 |
| Radius Health, Inc. | 3 | $54 |
| BETA Bionics, Inc. | 3 | $52 |
| Medtronic | 2 | $48 |
| Amphastar Pharmaceuticals, Inc. | 2 | $47 |
| Halozyme Inc | 2 | $41 |
| AstraZeneca | 2 | $32 |
| Ascensia Diabetes Care US Inc. | 2 | $31 |
| PBG Puerto Rico LLC | 1 | $24 |
| Ascendis Pharma Endocrinology Inc | 1 | $24 |
| Pfizer | 1 | $23 |
| IBSA Pharma Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $19 |
| Cardinal Health 414 LLC | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TOUJEO$125
- DEXCOM G7 GSS (161)$125
- TEPEZZA$124
- WATCHMAN Access System$118
- Creon$118
- CRYSVITA$115
How this compares
$4,283 in reported general payments places this provider in the 45th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Other endocrinology, diabetes & metabolism in Vega Baja
- Jose Garcia MateoPonce$945K
- Manuel Alegre-HernandezSan Juan$156K
- Monica Ortiz-RiveraSan Juan$148K
- Alex Gonzalez BossoloSan Juan$110K
- Michelle Mangual GarciaSan Juan$87K
- Meliza Martinez RodriguezSan Juan$80K
- Milliette Alvarado SantiagoRio Piedras$75K
- Altagracia Alcantara GonzalezBayamon$58K
- Jean Pujals KuryBayamon$50K
- Rafael GonzalezRio Piedras$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.